Last reviewed · How we verify
US-guided tenotomy with PRP — Competitive Intelligence Brief
phase 3
Orthopedics
Small molecule
Live · refreshed every 30 min
Target snapshot
US-guided tenotomy with PRP (US-guided tenotomy with PRP) — Jose Ignacio Martin. US-guided tenotomy with PRP is a minimally invasive procedure that uses ultrasound guidance to release tension in tendons and ligaments, with the addition of platelet-rich plasma (PRP) to promote healing.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| US-guided tenotomy with PRP TARGET | US-guided tenotomy with PRP | Jose Ignacio Martin | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- US-guided tenotomy with PRP CI watch — RSS
- US-guided tenotomy with PRP CI watch — Atom
- US-guided tenotomy with PRP CI watch — JSON
- US-guided tenotomy with PRP alone — RSS
Cite this brief
Drug Landscape (2026). US-guided tenotomy with PRP — Competitive Intelligence Brief. https://druglandscape.com/ci/us-guided-tenotomy-with-prp. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing